Featured Research

from universities, journals, and other organizations

Development of a safer vaccine for Alzheimer’s disease; Mouse study suggests new vaccine approach that may avoid side effects

Date:
November 17, 2010
Source:
Society for Neuroscience
Summary:
A new vaccine protects against memory problems associated with Alzheimer's disease, but without potentially dangerous side effects, a new animal study reports.

A new vaccine protects against memory problems associated with Alzheimer's disease, but without potentially dangerous side effects, a new animal study reports.

The research was presented at Neuroscience 2010, the annual meeting of the Society for Neuroscience, held in San Diego.

Vaccines against amyloid-beta accumulation in the brain, one of the hallmarks of Alzheimer's disease, have long been considered a promising approach to developing a treatment. But finding a vaccine that is both safe and effective has been challenging. Previous research in mice showed that a vaccine that targets the human version of amyloid-beta reduces learning and memory loss associated with the disease. However, the vaccine caused dangerous autoimmune inflammation of the brain during human clinical trials.

In the current study, researchers at the University of California, Irvine tested a vaccine developed against a non-human protein that had the same shape as amyloid-beta, but a different sequence of amino acid building blocks. The Alzheimer's mice that received the vaccine showed improved performance on memory and other cognitive tests. The vaccine also reduced the clumps of amyloid-beta and tau protein that may be toxic to brain cells.

"This finding is important because it shows that you don't need a human protein to get an immune response that will neutralize the toxic amyloid oligomers associated with Alzheimer's disease," said senior author Charles Glabe, PhD. Because the protein was not human, Glabe and his colleagues believe it is unlikely to cause the dangerous autoimmune response.

"We've demonstrated a promising approach to developing a safe, active vaccine -- and one potentially cheaper and easier to distribute than the manufactured vaccines currently in human trials," Glabe said.

Research was supported by Cure Alzheimer's Fund and the Larry L. Hillblom Foundation.


Story Source:

The above story is based on materials provided by Society for Neuroscience. Note: Materials may be edited for content and length.


Cite This Page:

Society for Neuroscience. "Development of a safer vaccine for Alzheimer’s disease; Mouse study suggests new vaccine approach that may avoid side effects." ScienceDaily. ScienceDaily, 17 November 2010. <www.sciencedaily.com/releases/2010/11/101116204730.htm>.
Society for Neuroscience. (2010, November 17). Development of a safer vaccine for Alzheimer’s disease; Mouse study suggests new vaccine approach that may avoid side effects. ScienceDaily. Retrieved September 18, 2014 from www.sciencedaily.com/releases/2010/11/101116204730.htm
Society for Neuroscience. "Development of a safer vaccine for Alzheimer’s disease; Mouse study suggests new vaccine approach that may avoid side effects." ScienceDaily. www.sciencedaily.com/releases/2010/11/101116204730.htm (accessed September 18, 2014).

Share This



More Mind & Brain News

Thursday, September 18, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Corporal Punishment on Decline, Debate Renews

Corporal Punishment on Decline, Debate Renews

AP (Sep. 16, 2014) Corporal punishment in the United States is on the decline, but there is renewed debate over its use after Minnesota Vikings running back Adrian Peterson was charged with child abuse. (Sept. 16) Video provided by AP
Powered by NewsLook.com
FDA Eyes Skin Shocks Used at Mass. School

FDA Eyes Skin Shocks Used at Mass. School

AP (Sep. 15, 2014) The FDA is considering whether to ban devices used by the Judge Rotenberg Educational Center in Canton, Massachusetts, the only place in the country known to use electrical skin shocks as aversive conditioning for aggressive patients. (Sept. 15) Video provided by AP
Powered by NewsLook.com
Shocker: Journalists Are Utterly Addicted To Coffee

Shocker: Journalists Are Utterly Addicted To Coffee

Newsy (Sep. 13, 2014) A U.K. survey found that journalists consumed the most amount of coffee, but that's only the tip of the coffee-related statistics iceberg. Video provided by Newsy
Powered by NewsLook.com
'Magic Mushrooms' Could Help Smokers Quit

'Magic Mushrooms' Could Help Smokers Quit

Newsy (Sep. 11, 2014) In a small study, researchers found that the majority of long-time smokers quit after taking psilocybin pills and undergoing therapy sessions. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins